Cargando…

Dynamic treatment regimes (DTRs) to study treatment sequencing in oncology: a scoping review protocol

INTRODUCTION: The rapid evolution of the therapeutic landscape in oncology poses challenges to optimal treatment sequencing. Evidence for clinical decision-making is often limited to studies focused on treatment evaluation at a single decision point, with limited capability of identifying delayed ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Esteves, Susana, Alves, João Miguel, Rodrigues, Pedro Pereira, Gomes da Silva, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254775/
https://www.ncbi.nlm.nih.gov/pubmed/37253495
http://dx.doi.org/10.1136/bmjopen-2022-067192
_version_ 1785056722073681920
author Esteves, Susana
Alves, João Miguel
Rodrigues, Pedro Pereira
Gomes da Silva, Maria
author_facet Esteves, Susana
Alves, João Miguel
Rodrigues, Pedro Pereira
Gomes da Silva, Maria
author_sort Esteves, Susana
collection PubMed
description INTRODUCTION: The rapid evolution of the therapeutic landscape in oncology poses challenges to optimal treatment sequencing. Evidence for clinical decision-making is often limited to studies focused on treatment evaluation at a single decision point, with limited capability of identifying delayed effects of prior treatment decisions on the efficacy and feasibility of future treatments. There is a growing interest in dynamic treatment regimes (DTRs) evaluation as it provides guidance on treatment individualisation based on evolving treatment and patient characteristics. In this scoping review we aim to systematically map how and to what extent DTRs have been evaluated in clinical studies to generate evidence for clinical decision-making in oncology. METHODS AND ANALYSIS: We will do a systematic literature search in MEDLINE (PubMed), Web of Science, Scopus and WHO international clinical trials registry platform to identify clinical studies (including protocols of ongoing studies), with either experimental or observational design, that aim to answer a clinical question and explore treatment sequencing issues in oncology using the concept of DTR. Data extraction will comprise information concerning cancer disease, clinical setting, treatments, tailoring variables, decision rules, decision points and outcomes, type of data, study design and statistical methods used for DTR evaluation. The review will be conducted according to Joanna Briggs Institute Reviewer’s manual for scoping reviews. No patients will be involved. ETHICS AND DISSEMINATION: Ethics committee approval is not required as this scoping review will undertake secondary analysis of published literature. Results will be disseminated through a peer-reviewed scientific journal and presented in relevant conferences. This scoping review will provide a better understanding of the methods used to generate evidence on treatment sequencing in oncology and will contribute to the identification of knowledge and methodological gaps that should be addressed.
format Online
Article
Text
id pubmed-10254775
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-102547752023-06-10 Dynamic treatment regimes (DTRs) to study treatment sequencing in oncology: a scoping review protocol Esteves, Susana Alves, João Miguel Rodrigues, Pedro Pereira Gomes da Silva, Maria BMJ Open Research Methods INTRODUCTION: The rapid evolution of the therapeutic landscape in oncology poses challenges to optimal treatment sequencing. Evidence for clinical decision-making is often limited to studies focused on treatment evaluation at a single decision point, with limited capability of identifying delayed effects of prior treatment decisions on the efficacy and feasibility of future treatments. There is a growing interest in dynamic treatment regimes (DTRs) evaluation as it provides guidance on treatment individualisation based on evolving treatment and patient characteristics. In this scoping review we aim to systematically map how and to what extent DTRs have been evaluated in clinical studies to generate evidence for clinical decision-making in oncology. METHODS AND ANALYSIS: We will do a systematic literature search in MEDLINE (PubMed), Web of Science, Scopus and WHO international clinical trials registry platform to identify clinical studies (including protocols of ongoing studies), with either experimental or observational design, that aim to answer a clinical question and explore treatment sequencing issues in oncology using the concept of DTR. Data extraction will comprise information concerning cancer disease, clinical setting, treatments, tailoring variables, decision rules, decision points and outcomes, type of data, study design and statistical methods used for DTR evaluation. The review will be conducted according to Joanna Briggs Institute Reviewer’s manual for scoping reviews. No patients will be involved. ETHICS AND DISSEMINATION: Ethics committee approval is not required as this scoping review will undertake secondary analysis of published literature. Results will be disseminated through a peer-reviewed scientific journal and presented in relevant conferences. This scoping review will provide a better understanding of the methods used to generate evidence on treatment sequencing in oncology and will contribute to the identification of knowledge and methodological gaps that should be addressed. BMJ Publishing Group 2023-05-30 /pmc/articles/PMC10254775/ /pubmed/37253495 http://dx.doi.org/10.1136/bmjopen-2022-067192 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Research Methods
Esteves, Susana
Alves, João Miguel
Rodrigues, Pedro Pereira
Gomes da Silva, Maria
Dynamic treatment regimes (DTRs) to study treatment sequencing in oncology: a scoping review protocol
title Dynamic treatment regimes (DTRs) to study treatment sequencing in oncology: a scoping review protocol
title_full Dynamic treatment regimes (DTRs) to study treatment sequencing in oncology: a scoping review protocol
title_fullStr Dynamic treatment regimes (DTRs) to study treatment sequencing in oncology: a scoping review protocol
title_full_unstemmed Dynamic treatment regimes (DTRs) to study treatment sequencing in oncology: a scoping review protocol
title_short Dynamic treatment regimes (DTRs) to study treatment sequencing in oncology: a scoping review protocol
title_sort dynamic treatment regimes (dtrs) to study treatment sequencing in oncology: a scoping review protocol
topic Research Methods
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254775/
https://www.ncbi.nlm.nih.gov/pubmed/37253495
http://dx.doi.org/10.1136/bmjopen-2022-067192
work_keys_str_mv AT estevessusana dynamictreatmentregimesdtrstostudytreatmentsequencinginoncologyascopingreviewprotocol
AT alvesjoaomiguel dynamictreatmentregimesdtrstostudytreatmentsequencinginoncologyascopingreviewprotocol
AT rodriguespedropereira dynamictreatmentregimesdtrstostudytreatmentsequencinginoncologyascopingreviewprotocol
AT gomesdasilvamaria dynamictreatmentregimesdtrstostudytreatmentsequencinginoncologyascopingreviewprotocol